Our mission is to provide research-based, actionable business recommendations for biotechnology, health technology and pharmaceutical firms. We leverage our analytical skills and scientific expertise to tackle strategic and economic problems to elevate a company’s performance.
Catalyst BioConsulting works with companies, large and small, on projects that have the potential to impact company growth and development. We are proud to have worked with these clients and more.
Catalyst BioConsulting Testimonials
“ReNeuroGen LLC is a virtual pharmaceutical company developing drug candidates for neurological disorders such as Stroke, Traumatic Brain Injury and Multiple Sclerosis. We have close ties to the Medical College of Wisconsin (MCW) since one of our co-founders, Dr. Kirkwood Pritchard is also a Professor at this institution. We worked with two different Catalyst BioConsulting [formerly known as PICO] teams on both ischemic stroke and multiple sclerosis projects in our first year of existence. Everybody, from the Director of the Catalyst BioConsulting program, team leaders and team members were truly superb in terms of responsiveness, clarity of thinking, effort and helpfulness. In particular, the Catalyst BioConsulting team contributions for the ischemic stroke project led to additional, novel insights into the science and business model being developed by the Company. MCW should be truly proud of such an innovative entrepreneurial program and any health, life science or biotech company looking for augmentive consulting help should strongly consider utilizing Catalyst BioConsulting services and its creative and hard working team members.”
Dr. Stephen Naylor, Co-Founder & CEO, Reneurogen LLC
“We are a small organization, so a couple of extra people never hurts. It’s outside, fresh ideas to say, ‘Hey have you thought about this’ or ‘Have you thought about that’. Just getting more people looking at the same problem who will get to a better answer, sooner.”“[They are] high energy people, they’re observant, they’re smart, they’re engaged. And I think part of this program’s success is that they have people who fit well into these types of environments.”
Dr. Chad Beyer, senior vice president of research and development, promentis pharmaceuticals
CTSI Discovery Radio interview, aired January 19, 2018
Frequently Asked Questions
Health Research Center, H2200
Medical College of Wisconsin
8701 Watertown Plank Rd.
Milwaukee, WI 53226